Bullish case
About $400 to $435
More likely if backlog converts on schedule, cloud and hardware revenue continue to scale, margins recover after deployment costs, and investors sustain a premium multiple for durable AI infrastructure earnings.
Cerebras Systems Inc. research snapshot
CBRS AI stock analysis currently treats Cerebras Systems as a high-growth AI infrastructure company whose wafer-scale systems and cloud services have real demand, but whose public-market record is very short and whose valuation leaves little room for missed execution. At the July 11, 2026 cutoff, the latest verified quote used here was $181.00, market capitalization was about $41.0 billion, and the central question was whether revenue growth, a $24.6 billion backlog, and customer wins can turn into durable gross margin and free cash flow. This is informational research, not investment advice.
Current price
$181.00
Market cap
About $41.0 billion
AI score
55 / 100
Rating
High-growth infrastructure, high execution and valuation risk
Trend status
New IPO with insufficient history for a 50-day or 200-day trend
Data cutoff (updated weekly)
July 11, 2026
Informational use only. This page is not investment advice.
| Dimension | Conclusion | Confidence |
|---|---|---|
| Business quality | Cerebras sells wafer-scale AI systems and cloud services for data-center-scale deployments, with Q1 2026 revenue up 94% year over year. | Medium-high |
| Moat | Wafer-scale engineering, systems integration, software, and deployment know-how may differentiate performance, but the moat is unproven against well-funded GPU and custom-silicon alternatives. | Medium |
| Management | Founder-led management has taken complex hardware from design to commercial systems. The public record is too short to judge capital allocation through a full cycle. | Medium |
| Financial trend | Q1 2026 revenue was $193.4 million and cash plus short-term investments were $3.3 billion, but GAAP net loss was $14.0 million and TTM free cash flow was negative. | High |
| Valuation | At $181.00, financial_rigor.py calculates about 127x TTM EPS and a negative free-cash-flow yield. The price requires strong growth and improving cash conversion. | Medium-high |
| Technical trend | CBRS has traded only since May 14, 2026. A valid 50-day average is not yet established and a 200-day average is unavailable. | High |
| Risk level | Risks include execution on backlog, customer concentration, data-center power and supply constraints, margin pressure, large-cap competition, share unlocks, and valuation compression. | High |
| AI confidence | Filings and Q1 results support the factual base, while forecasting confidence is constrained by a new listing and one reported quarter. | Medium |
| Investment certainty | Low to medium certainty. Product differentiation and demand visibility are promising, but the valuation and execution burden are unusually high. | Low-medium |
CBRS AI stock forecast
The CBRS AI stock forecast uses scenario ranges around the $181.00 cutoff price. It does not claim that AI can predict a specific future price. The ranges are outputs of an auditable three-year EPS and multiple scenario calculation, not price targets or promises.
About $400 to $435
More likely if backlog converts on schedule, cloud and hardware revenue continue to scale, margins recover after deployment costs, and investors sustain a premium multiple for durable AI infrastructure earnings.
About $155 to $170
More likely if revenue grows strongly but cash conversion and gross margin improve gradually, leaving the market to apply a lower, though still elevated, earnings multiple.
About $25 to $35
More likely if deployments slip, customers reduce commitments, margin pressure persists, dilution rises, or the market re-rates the stock toward a lower hardware multiple.
CBRS AI technical analysis
CBRS AI technical analysis is necessarily limited by the May 14, 2026 IPO date. The $181.00 price and the listed range are useful reference points, but there is not enough history for a credible 50-day average and no 200-day average. Confirm live data before acting.
| Level | Value | Why it matters |
|---|---|---|
| Current price | $181.00 | Latest verified quote used for this static page, as reported by StockAnalysis on July 8, 2026. |
| Near support | $160.81 to $176 | The $160.81 listed low marks the lower edge of the available post-IPO range. The $176 area was a July 7 intraday reference, not a guaranteed floor. |
| Near resistance | $185 to $192 | The $185 IPO price and the $192.01 July 7 prior-close reference are nearby supply areas to test with live volume. |
| 50-day moving average | Not established | CBRS had fewer than 50 trading sessions by the cutoff, so a 50-day signal would be incomplete. |
| 200-day moving average | Not available | The company has not traded long enough for a 200-day average. |
| Momentum | High volatility, limited history | The available range ran from $160.81 to $386.34. That range describes volatility, not a stable momentum signal. |
| Volume | About 2.0 million shares on July 7 | Use live volume and multiple sessions of trading history to judge breakout quality. |
| Volatility | Post-IPO range: $160.81 to $386.34 | Wide post-IPO swings make fixed-dollar stops and oversized positions especially fragile. |
| Invalidation | Sustained break below $160.81 | A sustained break below the available range low would invalidate a range-support setup and calls for a fresh thesis review. |
CBRS AI trading strategy
The CBRS AI trading strategy is a rules-based research framework, not personalized advice. A new IPO needs smaller position sizing, live-data confirmation, and explicit limits on loss before any setup is considered.
Wait for a move above the $185 to $192 reference area with expanding live volume, then check Q2 results, backlog conversion, gross-margin guidance, and whether price can hold above the breakout zone.
Do not treat a single volatile session as trend confirmation. Define loss limits before entry and reassess if the breakout fails.
If price approaches the $160.81 to $176 support area, look first for stabilization and updated fundamental evidence on customers, deployments, cash use, and margin before considering a range trade.
A break below the post-IPO range low invalidates the setup. Avoid averaging down solely because the stock is below its IPO price.
Track Q2 results, full-year revenue and gross-margin outlook, backlog conversion, cloud revenue, customer concentration, manufacturing capacity, working capital, free cash flow, and share unlocks.
Lower the rating if revenue growth does not convert into improving gross margin and free cash flow, or if concentration and dilution risks increase.
Investment research summary
Cerebras designs wafer-scale AI compute systems and software, then delivers hardware and cloud capacity for customers running large AI workloads.
Its potential moat is wafer-scale engineering plus systems and software integration. The key unanswered question is whether this performance advantage remains durable as competing AI hardware improves.
The thesis fails if backlog conversion slips, a concentrated customer base changes demand, supply or power constraints delay deployments, gross margin falls, or larger rivals narrow the performance gap.
Andrew Feldman leads a founder-built technical organization. The next public-market test is converting engineering ambition and financing into repeatable revenue, cash discipline, and shareholder-aware capital allocation.
AI inference and training demand are expanding, but data-center power, chip supply, model efficiency, custom silicon, and hyperscaler spending will determine how much value hardware vendors retain.
The $181.00 cutoff price implies that growth must persist and cash conversion must improve. With negative TTM free cash flow, a margin of safety would require more evidence than a large backlog alone.
Source-backed data
Every metric below includes a source and last verification date.
| Metric | Value | Source | Last verified |
|---|---|---|---|
| CBRS price, shares, and market capitalization | $181.00, 226.53 million shares, and about $41.00 billion market capitalization. financial_rigor.py price x shares calculation matched reported market cap. | StockAnalysis statistics and financial_rigor.py | July 11, 2026 |
| Q1 2026 revenue and gross margin | $193.4 million revenue, up 94% year over year, with 45% GAAP gross margin. | Cerebras Q1 2026 earnings release and SEC Form 10-Q | July 11, 2026 |
| FY 2025 revenue and net income | $509.99 million revenue and $237.8 million GAAP net income. The prospectus also reported operating losses, so GAAP net income should not be treated as recurring operating profitability. | SEC prospectus and StockAnalysis financials | July 11, 2026 |
| Cash and short-term investments | $3.3 billion at March 31, 2026. | Cerebras Q1 2026 earnings release and SEC Form 10-Q | July 11, 2026 |
| TTM cash flow and valuation math | TTM free cash flow was negative $359.24 million. financial_rigor.py calculated about 127.46x TTM PE and negative 0.88% free-cash-flow yield using $181.00 price, $1.42 EPS, and negative $1.59 FCF per share. | StockAnalysis statistics and financial_rigor.py | July 11, 2026 |
| Demand visibility and concentration risk | The prospectus disclosed $24.6 billion backlog, while public reporting highlighted material concentration in a small number of customers. Backlog is not the same as recognized revenue. | SEC prospectus | July 11, 2026 |
| Technical data limitation | Listed post-IPO range was $160.81 to $386.34. A 50-day average was incomplete and a 200-day average unavailable because trading began May 14, 2026. | StockAnalysis market data | July 11, 2026 |
This CBRS AI stock analysis is an informational tool for research and education only. It is not investment advice, a recommendation, or a guarantee of future performance. Forecast ranges are scenarios based on available data as of July 11, 2026 and can be wrong.
Design trading strategies visually with 10+ indicators. Set entry/exit conditions and risk management, then generate Pine Script code with no coding required.
Filter and discover stocks based on market cap, dividend yield, P/E ratio, sector, and more. Screen thousands of stocks with real-time data.
Smart AI-driven stock selection with fundamental screening, analyst estimates, and key metrics. Filter by P/E, market cap, dividends, and more.